Launch of Lenacapavir in South Africa for HIV prevention South Africa Helped Create Lenacapavir, Gilead Should Not Decide Who Gets It – African Alliance | SA News
Background: South Africa is preparing to rollout lenacapavir, the innovative, game changing twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) drug that was also researched in the Global South. On June 5, the President and the Health Minister will officially launch the roll-out of lenacapavir in South Africa in Secunda, billed as a ‘historic event’. But as our country – one with the world’s largest HIV epidemic – prepares to launch the drug that could end the epidemic, we must …
